7 Likes
There is another thread on this I think.
https://en.m.wikipedia.org/wiki/Brilaroxazine
4 Likes
Thanks for the info. Its a partial agonist so not too interested. I think abilify is partial agonist for only 1 receptor while this is partial for more. So perhaps its an improvement? Idk. Not too rxcited about it tbh but thanks for info.
4 Likes
Sounds better then anything available I would definitely try it. Internet said release date mid 2023
1 Like
The company said phase 3 estimated end spring 2023, the trial said estimated completion December 2023.? They do not match. Then they have to publish results and prepare NDA. The FDA reviews NDA application for 9-10 months, assuming they do not reject it right away.
https://clinicaltrials.gov/ct2/show/NCT05184335?term=Brilaroxazine&draw=2&rank=1
I did not know rexulti was that ineffective lol
1 Like